Current trends in management of STEMI in the Slovak republic. The analysis of the Slovaks-2 registry from 2011;Aktuálne trendy v starostlivosti o pacientov so STEMI v Slovenskej republike. Analýza výsledkov registra Slovaks-2 z roku 2011

Cardiology Letters

Volumn 22, Issue 2, 2013, Pages 115-124

  Studencan M ^a   Kovar F ^b   Hricak V ^c   Kurray, P ^d   Goncalvesova E ^c   Kamensky G ^e  

^a Kardiocentrum FNsP J A Reimana   (Slovakia)

^b I internej kliniky Univerzitnej nemocnice v Martine   (Slovakia)

^c Národného ústavu srdcov ých a cievnych chorôb a s v Bratislave   (Slovakia)

^d Sro v Nitre ^*  (Slovakia)

^e V internej kliniky Univerzitnej nemocnice   (Slovakia)

Author keywords

Acute coronary syndrome; Mortality; Primary PCI; Registry; Reperfusion treatment; SLOVAKS; STEMI; Time intervals; Transport

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; CARDIOGENIC SHOCK; CARDIOVASCULAR MORTALITY; DEATH; ELECTROCARDIOGRAM; FEMALE; FIBRINOLYSIS; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; REGISTER; REPERFUSION; SLOVAKIA; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

EID: 84877700288     PISSN: 13383655     EISSN: 13383760     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Studenčan M, Hricak V, Kovař F, Kurray P, Murin J, Kamensky G, et al. Vyznam cielenych organizačnych opatreni pre implementaciu oficialnych odporučani pre manažment pacientov so STEMI do klinickej praxe. Analyza vysledkov registra SLOVAKS 2007 - 2008. Cardiology sk 2010;19(1):55-67.
2. Kovař F, Studenčan M, Hricak V, Kurray P, Murin J, Kamensky G, et al. Manažment pacientov s akutnym koronarnym syndromom bez elevacii segmentov ST. Analyza vysledkov registra SLOVAKS z roku 2008. Cardiology sk 2010;19(3):181-191.
3. Studenčan M. SLOvensky register Akutnych Koronarnych Syndromov - SLOVAKS. Ďalšie smerovanie. Cardiology Lett. 2011;20(3):204-206.
4. Widimsky P, Zelizko M, Jansky P, Tousek F, Holm F, Aschermann M. The incidence, treatment strategies and outcomes of acute coronary syndromes in the "reperfusion network" of different hospital types in the Czech Republic: results of the Czech evaluation of acute coronary syndromes in hospitalized patients (CZECH) registry. Int. J. Cardiol. 2007;119(2):212-219.
5. Widimsky P, Wijns W, Fajadet J, de Belder M, Knot J, Aaberge L, et al. Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. Eur Heart J 2010;31(8):943-957.
6. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet 1988;2(8607):349-360.
7. Cagaň S, Moťovska Z, Besedova I, Jurkovičova O, Wimmerova S. Manažment akutneho infarktu myokardu. Kompendium mediciny. Mimoriadna priloha zdravotnickych novin 2004:3-31.
8. Lowel H, Meisinger C, Heier M, Hormann A. The populationbased acute myocardial infarction (AMI) registry of the MONICA/KORA study region of Augsburg. Gesundheitswesen 2005;67(Suppl 1):S31-37.
9. Selker HP, Raitt MH, Schmid CH, Laks MM, Beshansky JR, Griffith JL, et al. Time-dependent predictors of primary cardiac arrest in patients with acute myocardial infarction. Am Journal Cardiol 2003;91(3):280-286.
10. White HD, Chew DP. Acute myocardial infarction. Lancet 2008;372(9638):570-584.
11. Steg PG, James SK, Atar D, Badano LP, Lundqvist CB, Borger MA, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). Eur Heart J 2012;33(20):2569-2619.
12. Montalescot G, Wiviott SD, Braunwald E, Murphy SA, Gibson CM, McCabe CH, et al. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITONTIMI 38): double-blind, randomised controlled trial. Lancet 2009;373(9665):723-731.
13. Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Eng J Med 2009;361(11):1045-1057.
14. Steg PG, James S, Harrington RA, Ardissino D, Becker RC, Cannon CP, et al. Ticagrelor versus clopidogrel in patients with STelevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis. Circulation 2010;122(21):2131-2141.
15. Silvain J, Montalescot G. Anticoagulant for primary percutaneous coronary intervention - the last dance for unfractionated heparin? Archives of cardiovascular diseases 2012;105(5):259-261.
16. Studenčan M, Hricak V, Kovař F, Dobiaš V, Kurray P, Fridrich V, Čenčarik J, Mečiar P. Včasny manažment akutneho infarktu myokardu s elevaciami ST na EKG (STEMI). Odporučania Slovenskej kardiologickej spoločnosti a Spoločnosti urgentnej mediciny a mediciny katastrof. Cardiology Lett. 2013;22(1):85-93.
17. Waksman R. Outcome improvement for STEMI patients: The next breakthrough in Interventional Cardiology. Cardiovasc Rev Med 2013:14 (1):1-2.